Literature DB >> 2666142

Monoclonal antibody 5.5 reacts with p8,14, a myeloid molecule associated with some vascular endothelium.

N Hogg1, C Allen, J Edgeworth.   

Abstract

The movement of mononuclear phagocytes and neutrophils from the circulation into tissues is a process which is not completely understood. Monoclonal antibody 5.5 is specific for an 8/14-kDa molecule known variously as the CF antigen, L1 molecule or MRP8 and 14. We show that this molecule, which will be named p8,14 in this study, is expressed in all circulating monocytes and neutrophils as an intracellular product (as well as some types of epithelium). Tissue staining patterns suggest that when monocytes and neutrophils adhere to vascular endothelium, they release this molecule onto the associated endothelium. This process occurs with single monocytes and when monocytes form part of an inflammatory infiltrate. Monoclonal antibody 5.5 does not react with cultured endothelial cells even when stimulated with phorbol ester, tumor necrosis factor, interferon-gamma or interleukin 1 alpha providing further evidence that myeloid cells are the source of the p8,14 in this interactive process. Monocytes which have moved further into such tissues and tissue macrophages in general are monoclonal antibody 5.5 negative, suggesting that the ability to synthesize this molecule may be lost when monocytes leave the circulation and enter tissues. These results indicate that p8,14 plays a role in the interaction between myeloid cells and the vascular endothelium to which they adhere prior to leaving the circulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666142     DOI: 10.1002/eji.1830190615

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

1.  Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.

Authors:  Koichi Shimizu; Peter Libby; Viviane Z Rocha; Eduardo J Folco; Rica Shubiki; Nir Grabie; Sunyoung Jang; Andrew H Lichtman; Ayako Shimizu; Nancy Hogg; Daniel I Simon; Richard N Mitchell; Kevin Croce
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

2.  Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex.

Authors:  Sharof Tugizov; Jennifer Berline; Rossana Herrera; Maria Elena Penaranda; Mayumi Nakagawa; Joel Palefsky
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 3.  Multifarious diagnostic possibilities of the S100 protein family: predominantly in pediatrics and neonatology.

Authors:  Anna Medkova; Josef Srovnal; Jarmila Potomkova; Jana Volejnikova; Vladimir Mihal
Journal:  World J Pediatr       Date:  2018-06-01       Impact factor: 2.764

4.  Platelet-Derived MRP-14 Induces Monocyte Activation in Patients With Symptomatic Peripheral Artery Disease.

Authors:  Rebecca Dann; Tarik Hadi; Emilie Montenont; Ludovic Boytard; Dornaszadat Alebrahim; Jordyn Feinstein; Nicole Allen; Russell Simon; Krista Barone; Kunihiro Uryu; Yu Guo; Caron Rockman; Bhama Ramkhelawon; Jeffrey S Berger
Journal:  J Am Coll Cardiol       Date:  2018-01-02       Impact factor: 24.094

5.  An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes.

Authors:  G Bouma; J M C Coppens; W-K Lam-Tse; W Luini; K Sintnicolaas; W H Levering; S Sozzani; H A Drexhage; M A Versnel
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

6.  An immunohistochemical analysis of onchocercal nodules: evidence for an interaction between macrophage MRP8/MRP14 and adult Onchocerca volvulus.

Authors:  J D Edgeworth; A Abiose; B R Jones
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

7.  Expression of the calcium-binding proteins MRP8 and MRP14 in monocytes is regulated by a calcium-induced suppressor mechanism.

Authors:  J Roth; M Goebeler; V Wrocklage; C van den Bos; C Sorg
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

8.  Myeloid cell function in MRP-14 (S100A9) null mice.

Authors:  Josie A R Hobbs; Richard May; Kiki Tanousis; Eileen McNeill; Margaret Mathies; Christoffer Gebhardt; Robert Henderson; Matthew J Robinson; Nancy Hogg
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Serum 27E10 antigen: a new potential marker for staging HIV disease.

Authors:  N Lügering; R Stoll; T Kucharzik; G Burmeister; C Sorg; W Domschke
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 10.  Novel insights into the role of S100A8/A9 in skin biology.

Authors:  Claus Kerkhoff; Andreas Voss; Thomas E Scholzen; Michelle M Averill; Kurt S Zänker; Karin E Bornfeldt
Journal:  Exp Dermatol       Date:  2012-08-09       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.